Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 1INDIV 1

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms, Plasma Cell 3Myasthenia Gravis 3Neoplasms 2Lymphoma 2Leukemia 2Infections 2Neuromyelitis Optica 1Myelitis, Transverse 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Limbic Encephalitis 1Immunoglobulin Light-chain Amyloidosis 1Epilepsy 1Epilepsies, Partial 1Drug Resistant Epilepsy 1Autoimmune Diseases of the Nervous System 1Autoimmune Diseases 1

Interventions

Rituximab 7Pyridostigmine Bromide 5Prednisone 5efgartigimod alfa 4Hizentra 4telitacicept 3Immunoglobulins, Intravenous 3Cyclophosphamide 3Azathioprine 3thymoglobulin 2fludarabine 2Thymectomy 2Steroids 2Mycophenolic Acid 2Data Collection 2Blood Specimen Collection 2zilucoplan 1tofacitinib 1tocilizumab 1talquetamab 1sargramostim 1rozanolixizumab 1prednylidene 1gamma-Globulins 1deltacortene 1carmustine, poliferprosan 20 drug combination 1bu-zhong-yi-qi-tang 1apraclonidine 1Walk Test 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Myasthenia Gravis × Immunoglobulins, Intravenous × Clear all
NCT07532707 2026-04-16

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

Damascus University

Phase NA Completed
50 enrolled

Myasthenia Gravis

NCT04728425 2025-04-27

MG_SCIG

University Health Network, Toronto

Phase 2 Completed
30 enrolled

Myasthenia Gravis

NCT01179893 2010-08-11

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

University Health Network, Toronto

Phase 4 Completed
87 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡